Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Nanjing University School Of Medicine

Clinical trials sponsored by Nanjing University School Of Medicine, explained in plain language.

Trials to join now! 1

Breakthrough biologics battle standard lupus treatment in kidney disease trial

Disease control Recruiting now

This study compares two newer biologic drugs (Belimumab and Telitacicept) against the current standard treatment for lupus-related kidney inflammation. Fifty patients with active lupus nephritis will receive either the biologic drugs alone, standard therapy, or a combination of b…

Phase: PHASE2 • Sponsor: Nanjing University School of Medicine • Aim: Disease control

Last updated Apr 04, 2026 08:22 UTC